Clinical Trial News Archive - February 2019
Get news by email or subscribe to our news feeds.
February 4, 2019
- VLP Therapeutics Receives FDA Clearance of Investigational New Drug Application and Initiates First Clinical Trial of VLPM01 Malaria Vaccine
- Biohaven Achieves Targeted Therapeutic Exposures of BHV-3500, a Third-Generation Small Molecule CGRP Receptor Agonist
February 5, 2019
February 8, 2019
February 11, 2019
- Gilead Announces Topline Data From Phase 3 STELLAR-4 Study of Selonsertib in Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)
- Sanofi and Regeneron Offer Praluent (alirocumab) at a New Reduced U.S. List Price
- Apellis Pharmaceuticals’ APL-2 Receives Fast Track Designation from the FDA for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria
- FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis
February 15, 2019
February 18, 2019
February 19, 2019
- Biohaven's Verdiperstat Receives Orphan Drug Designation From FDA For Multiple System Atrophy
- Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
February 20, 2019
- Immunomedics Announces Publication of Triple-Negative Breast Cancer Data With Sacituzumab Govitecan in the New England Journal of Medicine
- Biohaven Enrolls First Patient In Phase 3 Generalized Anxiety Disorder (GAD) Trial Of Troriluzole
February 21, 2019
February 23, 2019
February 25, 2019
February 28, 2019
Clinical Trial Results Archive
2020January, February, March, April, May, June, July, August
2019January, February, March, April, May, June, July, August, September, October, November, December
2018January, February, March, April, May, June, July, August, September, October, November, December
2017August, September, October, November, December
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
